{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:26:04Z","timestamp":1791595564517,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Hospital Medical-Engineering Special Project on AI-Driven Multimodal Wearable Intelligent Monitoring System for Cardiovascular Diseases: From Development to Clinical Translation","award":["BJ-2025-157"],"award-info":[{"award-number":["BJ-2025-157"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02169-1","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:02:47Z","timestamp":1783735367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of CTI and its modified indices in predicting cardiovascular disease risk across different glycemic statuses: a nationwide prospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Xinjiang","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"25","key":"2169_CR1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJL, Roth GA, Global Burden of Cardiovascular Diseases and Risks Collaborators. Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol. 2023;82(25):2350\u2013473. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.007.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"2169_CR2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.005.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2169_CR3","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1111\/dom.16529","volume":"27","author":"X Dong","year":"2025","unstructured":"Dong X, Wang J, Wang C, et al. Worldwide burden of metabolic risk-related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Diabetes Obes Metab. 2025;27(9):4859\u201382. https:\/\/doi.org\/10.1111\/dom.16529.","journal-title":"Diabetes Obes Metab"},{"key":"2169_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1175174","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z. Inflammation biomarkers are associated with the incidence of cardiovascular disease: A meta-analysis. Front Cardiovasc Med. 2023;10:1175174. https:\/\/doi.org\/10.3389\/fcvm.2023.1175174.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2169_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1751-7176.2011.00560.x","volume":"14","author":"A Barac","year":"2012","unstructured":"Barac A, Wang H, Shara NM, et al. Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: The Strong Heart Study. J Clin Hypertens (Greenwich). 2012;14(1):13\u20139. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00560.x.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"2169_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02651-6","volume":"24","author":"Y Feng","year":"2025","unstructured":"Feng Y, Yin L, Huang H, Hu Y, Lin S. Assessing the impact of insulin resistance trajectories on cardiovascular disease risk using longitudinal targeted maximum likelihood estimation. Cardiovasc Diabetol. 2025;24(1):112. https:\/\/doi.org\/10.1186\/s12933-025-02651-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2169_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, Papakonstantinou EJ, Salamou E, Guzman E. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548. https:\/\/doi.org\/10.1177\/03000605231164548.","journal-title":"J Int Med Res"},{"issue":"1","key":"2169_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79673-9","volume":"14","author":"J Huang","year":"2024","unstructured":"Huang J, Zhang J, Li L, et al. Triglyceride-glucose index and hsCRP-to-albumin ratio as predictors of major adverse cardiovascular events in STEMI patients with hypertension. Sci Rep. 2024;14(1):28112. https:\/\/doi.org\/10.1038\/s41598-024-79673-9.","journal-title":"Sci Rep"},{"issue":"1","key":"2169_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2486594","volume":"57","author":"Z Gui","year":"2025","unstructured":"Gui Z, Chen X, Wang D, et al. Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk. Ann Med. 2025;57(1):2486594. https:\/\/doi.org\/10.1080\/07853890.2025.2486594.","journal-title":"Ann Med"},{"issue":"1","key":"2169_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10654-020-00681-w","volume":"36","author":"G Markozannes","year":"2021","unstructured":"Markozannes G, Koutsioumpa C, Cividini S, et al. Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies. Eur J Epidemiol. 2021;36(1):11\u201336. https:\/\/doi.org\/10.1007\/s10654-020-00681-w.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"2169_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/HCO.0000000000001215","volume":"40","author":"JE Chia","year":"2025","unstructured":"Chia JE, Ang SP. Elevated C-reactive protein and cardiovascular risk. Curr Opin Cardiol. 2025;40(4):237\u201343. https:\/\/doi.org\/10.1097\/HCO.0000000000001215.","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"2169_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-02928-6","volume":"37","author":"L Zheng","year":"2025","unstructured":"Zheng L, Ye J, Liao X, Li J, Wang Q, Wang F. Frailty, high-sensitivity C-reactive protein and cardiovascular disease: a nationwide prospective cohort study. Aging Clin Exp Res. 2025;37(1):58. https:\/\/doi.org\/10.1007\/s40520-025-02928-6.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"2169_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023;22(1):279. https:\/\/doi.org\/10.1186\/s12933-023-02030-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156. https:\/\/doi.org\/10.1186\/s12933-024-02244-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142. https:\/\/doi.org\/10.1186\/s12933-025-02686-9.","journal-title":"Cardiovasc Diabetol"},{"key":"2169_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1485538","volume":"11","author":"M Xu","year":"2024","unstructured":"Xu M, Zhang L, Xu D, Shi W, Zhang W. Usefulness of C-reactive protein-triglyceride glucose index in detecting prevalent coronary heart disease: findings from the national health and nutrition examination survey 1999-2018. Front Cardiovasc Med. 2024;11:1485538. https:\/\/doi.org\/10.3389\/fcvm.2024.1485538.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"2169_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715\u201325. https:\/\/doi.org\/10.1016\/S2213-8587(19)30084-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2169_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"2169_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"issue":"10086","key":"2169_CR21","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(17)31437-X","volume":"389","author":"KM Flegal","year":"2017","unstructured":"Flegal KM. Body-mass index and all-cause mortality. Lancet. 2017;389(10086):2284\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(17)31437-X.","journal-title":"Lancet"},{"issue":"1","key":"2169_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Qi Y, Song J, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol. 2024;23(1):185. https:\/\/doi.org\/10.1186\/s12933-024-02278-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254. https:\/\/doi.org\/10.1186\/s12933-025-02784-8.","journal-title":"Cardiovasc Diabetol"},{"key":"2169_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-025-04575-w","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Zhou D, Chen Y, Huo G. Association of cholesterol, high-density lipoprotein, and glucose index and its modified indices with the risk of stroke: insights from CHARLS. BMC Neurol. 2025. https:\/\/doi.org\/10.1186\/s12883-025-04575-w.","journal-title":"BMC Neurol"},{"key":"2169_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol (Lausanne). 2022;13:905266. https:\/\/doi.org\/10.3389\/fendo.2022.905266.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2169_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1381612825666190408122557","volume":"25","author":"S Zhang","year":"2019","unstructured":"Zhang S, Wang Y, Cheng J, et al. Hyperuricemia and cardiovascular disease. Curr Pharm Des. 2019;25(6):700\u20139. https:\/\/doi.org\/10.2174\/1381612825666190408122557.","journal-title":"Curr Pharm Des"},{"key":"2169_CR27","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.mex.2019.11.008","volume":"6","author":"EM Tanner","year":"2019","unstructured":"Tanner EM, Bornehag CG, Gennings C. Repeated holdout validation for weighted quantile sum regression. MethodsX. 2019;6:2855\u201360. https:\/\/doi.org\/10.1016\/j.mex.2019.11.008.","journal-title":"MethodsX"},{"issue":"1","key":"2169_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04091-8","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, He W, Ji Y, Wang Q, Li X. A linear positive association between high-sensitivity C-reactive protein and the prevalence of cardiovascular disease among individuals with diabetes. BMC Cardiovasc Disord. 2024;24(1):411. https:\/\/doi.org\/10.1186\/s12872-024-04091-8.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"2169_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128987","volume":"10","author":"E Seven","year":"2015","unstructured":"Seven E, Husemoen LL, Sehested TS, et al. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study. PLoS ONE. 2015;10(6):e0128987. https:\/\/doi.org\/10.1371\/journal.pone.0128987.","journal-title":"PLoS ONE"},{"issue":"1","key":"2169_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124. https:\/\/doi.org\/10.1186\/s12933-022-01546-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02261-8","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D. The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged\u2009\u2264\u200965 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):168. https:\/\/doi.org\/10.1186\/s12933-024-02261-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2169_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/03014460.2022.2049874","volume":"49","author":"T Wu","year":"2022","unstructured":"Wu T, Wei B, Song YP, et al. Predictive power of a body shape index and traditional anthropometric indicators for cardiovascular disease: a cohort study in rural Xinjiang, China. Ann Hum Biol. 2022;49(1):27\u201334. https:\/\/doi.org\/10.1080\/03014460.2022.2049874.","journal-title":"Ann Hum Biol"},{"key":"2169_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112516","volume":"194","author":"Y He","year":"2024","unstructured":"He Y, Shi L. Anthropometric indicators and cardiovascular diseases risk in pre-diabetic and diabetic adults: NHANES 1999-2018 cross-sectional analysis. Exp Gerontol. 2024;194:112516. https:\/\/doi.org\/10.1016\/j.exger.2024.112516.","journal-title":"Exp Gerontol"},{"issue":"1","key":"2169_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56. https:\/\/doi.org\/10.1038\/s41572-019-0106-z.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2169_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030080","volume":"8","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Xian X, Wang Z, et al. Research progress on the relationship between atherosclerosis and inflammation. Biomolecules. 2018;8(3):80. https:\/\/doi.org\/10.3390\/biom8030080.","journal-title":"Biomolecules"},{"issue":"9","key":"2169_CR36","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545.","journal-title":"Circ Res"},{"key":"2169_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.983723","volume":"13","author":"L Mao","year":"2022","unstructured":"Mao L, Yin R, Yang L, Zhao D. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis. Front Endocrinol (Lausanne). 2022;13:983723. https:\/\/doi.org\/10.3389\/fendo.2022.983723.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2169_CR38","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120(7):1183\u201396. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.309715.","journal-title":"Circ Res"},{"key":"2169_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108907","volume":"100","author":"C Gei\u00dfler","year":"2022","unstructured":"Gei\u00dfler C, Krause C, Neumann AM, et al. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem. 2022;100:108907. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108907.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"2169_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.496","volume":"5","author":"Y Long","year":"2024","unstructured":"Long Y, Mao C, Liu S, Tao Y, Xiao D. Epigenetic modifications in obesity-associated diseases. MedComm (2020). 2024;5(2):e496. https:\/\/doi.org\/10.1002\/mco2.496.","journal-title":"MedComm (2020)"},{"issue":"1","key":"2169_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009836","volume":"6","author":"M Ning","year":"2016","unstructured":"Ning M, Zhang Q, Yang M. Comparison of self-reported and biomedical data on hypertension and diabetes: findings from the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2016;6(1):e009836. https:\/\/doi.org\/10.1136\/bmjopen-2015-009836.","journal-title":"BMJ Open"},{"key":"2169_CR42","doi-asserted-by":"publisher","DOI":"10.20517\/mtod.2023.58","volume":"4","author":"M Noble","year":"2024","unstructured":"Noble M, Cahill D. Hypogonadism: cardiometabolism and gonadal function in men. Metab Target Organ Damage. 2024;4:14. https:\/\/doi.org\/10.20517\/mtod.2023.58.","journal-title":"Metab Target Organ Damage"},{"key":"2169_CR43","doi-asserted-by":"publisher","DOI":"10.20517\/mtod.2024.42","volume":"4","author":"A Lonardo","year":"2024","unstructured":"Lonardo A, Ballestri S, Baffy G, Weiskirchen R. Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease. Metab Target Organ Damage. 2024;4:41. https:\/\/doi.org\/10.20517\/mtod.2024.42.","journal-title":"Metab Target Organ Damage"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02169-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:11:06Z","timestamp":1787213466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02169-1","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS study adhered to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Peking University. Written informed consent was obtained from all participants prior to their involvement in the study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"178"}}